Select language:  
1800 620 420
Close menu

Optimal Care Pathways for patients

Your guide to the best cancer care

An illustration of two people embracing, with the text Optimal Care Pathways for patients and loved ones over the top.
When you or someone you care for is diagnosed with blood cancer, you want to make sure you’ve got all the information you need – but finding the right information online can be confusing.

You’ve come to the right place.

The Guides to Best Cancer Care are specially designed to support people in Australia who are diagnosed with blood cancer, and their loved ones. You’ll get help with understanding the diagnosis, treatment and care options, some questions you may want to ask your doctor, and what support services are available to you and details about how to access them.

Each of these guides have been developed by Australia’s leading blood cancer specialists, alongside people who have been through blood cancer themselves.

The Blood Cancer Taskforce, with support from the Leukaemia Foundation, have collaborated with the Cancer Council to house all the different Guides to Best Cancer Care in one place. Just click on the disease group that’s relevant to you below, and you’ll be linked straight through to the right guide on the Cancer Council website. You can also view all available guides here.

The Guides to Best Cancer Care are also available in Simplified Chinese, Traditional Chinese, Vietnamese, Arabic, Italian, Greek, Tagalog and Hindi.


Optimal Care Pathways are available for the following blood cancer and disorder types:

AL-amyloidosis Optimal Care Pathway

AL-amyloidosis

This blood disorder can affect your body’s organs and tissues

Leukaemia Optimal Care Pathways

Leukaemia

These cancers develop in the bone marrow, disrupting normal blood cell functions

Lymphoma Optimal Care Pathways

Lymphoma

Lymphomas develop in the lymphatic system, weakening important immune functions

Myeloma Optimal Care Pathways

Myeloma

Myeloma develops in the plasma cells, impacting bones and blood

Myelodysplastic syndromes (MDS) Optimal Care Pathways

Myelodysplastic syndromes (MDS)

MDS affects the production of normal blood cells in the bone marrow

Myeloproliferative neoplasms (MPN) Optimal Care Pathways

Myeloproliferative neoplasms (MPN)

Myeloproliferative neoplasms (MPN) are a rare group of blood cancers


More blood cancer treatment information

The impact of clear, accessible treatment information

Graham Lewis sits outside, holding on to his mobility walker
Prior to his blood cancer diagnosis, Graham was an avid cyclist and cricketer

“It’s important that medical advice and treatment options are available to everyone who enters the blood cancer arena.”

Graham, who was diagnosed with blood cancer in 2010, has suffered a severe decrease in physical ability due to his treatment – something he thinks could have been avoided had his treating team had a clearer direction.

“If everyone was singing from the same hymn sheet and following the best practice set out in an OCP,” says Graham, “those variables would have less impact.”

Read Graham’s story here


Last updated on May 14th, 2024

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.